EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Analytical Performance Evaluation of the Cardiac Troponin T High Sensitivity Gen 6 Assay

Marko Knoll, Lori B Daniels iD, Christian Mueller iD, Nicholas L Mills iD, Evangelos Giannitsis iD, Alisa F A Rösser, Dunja Kurtoic, Annika Wahl, Richard Body iD, Robert H Christenson, Christa Cobbaert, Christopher R deFilippi und 14 weitere

The Journal of Applied Laboratory Medicine · 03.09.2026 · 11 (5) · 1009-1025

DOI: 10.1093/jalm/jfag031 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift The Journal of Applied Laboratory Medicine, online erschienen am 26.03.2026. Verfasst von Marko Knoll und 25 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Roche Diagnostics GmbH, Penzberg, Germany. Hauptthemen laut MEDLINE: Troponin T, Myocardial Infarction. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche Diagnostics GmbH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

High-sensitivity cardiac troponin (hs-cTn) assays are recommended for the diagnosis of acute myocardial infarction. Here, we characterize the analytical performance of a next-generation hs-cTn assay, Elecsys® Troponin T hs Gen 6 (Roche Diagnostics International).

Methods

Surplus lithium-heparin plasma or serum samples from patients or healthy volunteers were run on Cobas® e 801, e 402, and Pro analyzers. Limits of blank (LoB), limits of detection (LoD), and limits of quantitation (LoQ) were determined according to CLSI EP17-A2, with target values of 1.0 and 1.5 ng/L for LoB/LoD and 3.0 ng/L (10% CV) and 1.5 ng/L (20% CV) for LoQ, respectively. Precision was measured, per CLSI EP17-A2, using 3 QC samples (approximately 4, 30, and 220 ng/L), 12 native samples, and 3 reagent lots. Linearity, per CLSI EP06-Ed2, was determined by diluting samples with cardiac troponin T (cTnT) concentration above the measuring range with a low/blank sample. Interference (per Glick) with endogenous and assay components at 5 cTnT concentrations was assessed.

Results

Measured values for LoB, LoD, and LoQ at 10% and 20% CV were 0.1 to 0.7 ng/L, 0.3 to 1.4 ng/L, 1.0 to 2.9 ng/L, and 0.4 to 1.2 ng/L, respectively. Repeatability CVs were 1.0 to 5.8% for mean cTnT concentrations of 2.6 to 9230 ng/L in lithium-heparin plasma. High precision was shown across lots, and linearity was observed across the measuring range (1.5 to 9500 ng/L, all Pearson's r = 1.00). No interferences were observed, specified up to ≤1000 mg/dL hemoglobin, ≤50 mg/dL [≤855 µmol/L] icterus/bilirubin, and ≤1200 ng/mL biotin.

Conclusions

The analytical performance characterization of the assay demonstrated high sensitivity, high precision at the low end and across the measuring range, and resistance to interference.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Troponin TMyocardial InfarctionHumansReproducibility of ResultsLimit of DetectionSensitivity and SpecificityBiomarkersImmunoassay

Substanzen

Troponin TBiomarkers

Autor:innen und Institutionen

  • Research and Development, Roche Diagnostics GmbH, Penzberg, Germany.
  • Division of Cardiovascular Medicine, Department of Medicine, University of California San Diego, La Jolla, CA, United States.
  • Cardiovascular Research Institute Basel and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.
  • British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
  • Department of Internal Medicine III, Cardiology University Hospital of Heidelberg, Heidelberg, Germany.
  • Clinical Biostatistics, Roche Diagnostics International GmbH, Penzberg, Germany.

ORCID-Profile: Lori B Daniels, Christian Mueller, Nicholas L Mills, Evangelos Giannitsis, Richard Body, Kai M Eggers, Allan S Jaffe, Johannes T Neumann, Yader Sandoval, Jack Wei Chieh Tan, Martin P Than, Raphael Twerenbold

Förderung

  • Roche Diagnostics GmbH

Zitieren

APA

Knoll, M., Daniels, L. B., Mueller, C., Mills, N. L., Giannitsis, E., Rösser, A. F. A., Kurtoic, D., Wahl, A., Body, R., Christenson, R. H., Cobbaert, C., deFilippi, C. R., Eggers, K. M., Inoue, K., Jaffe, A. S., McCarthy, C. P., McCord, J., Neumann, J. T., Omland, T., …, & Meex, S. J. R. (2026). Analytical Performance Evaluation of the Cardiac Troponin T High Sensitivity Gen 6 Assay. The Journal of Applied Laboratory Medicine, 11(5), 1009-1025. https://doi.org/10.1093/jalm/jfag031

Vancouver

Knoll M, Daniels LB, Mueller C, Mills NL, Giannitsis E, Rösser AFA, et al. Analytical Performance Evaluation of the Cardiac Troponin T High Sensitivity Gen 6 Assay. The Journal of Applied Laboratory Medicine. 2026;11(5):1009-1025. doi:10.1093/jalm/jfag031

BibTeX
@article{Knoll2026,
  author = {Knoll, Marko and Daniels, Lori B and Mueller, Christian and Mills, Nicholas L and Giannitsis, Evangelos and Rösser, Alisa F A and Kurtoic, Dunja and Wahl, Annika and Body, Richard and Christenson, Robert H and Cobbaert, Christa and deFilippi, Christopher R and Eggers, Kai M and Inoue, Kenji and Jaffe, Allan S and McCarthy, Cian P and McCord, James and Neumann, Johannes T and Omland, Torbjørn and Papendick, Cynthia and Sandoval, Yader and Tan, Jack Wei Chieh and Than, Martin P and Twerenbold, Raphael and Peacock, W Frank and Meex, Steven J R},
  title = {Analytical Performance Evaluation of the Cardiac Troponin T High Sensitivity Gen 6 Assay},
  journal = {The Journal of Applied Laboratory Medicine},
  year = {2026},
  volume = {11},
  number = {5},
  pages = {1009--1025},
  doi = {10.1093/jalm/jfag031}
}
Kostenlos starten →